NCT03915925

Brief Summary

This is a prospective, observational, multicenter cohort study to compare right ventricular dysfunction dependent and independent prognostic models for short-term serous adverse events in patients who are diagnosed with pulmonary embolism in the emergency department. Clinical endpoints are assessed at days 1-5. A thirty-day follow-up phone call is conducted to obtain further clinical endpoints and a quality of life assessment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
935

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2018

Typical duration for all trials

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 12, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 16, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2020

Completed
Last Updated

April 27, 2022

Status Verified

July 1, 2019

Enrollment Period

2.2 years

First QC Date

April 12, 2019

Last Update Submit

April 20, 2022

Conditions

Keywords

right ventricle dysfunctionprediction modelfunctional outcomes

Outcome Measures

Primary Outcomes (1)

  • Compare the risk ratio odds ratio of different PE risk stratification models for clinical Deterioration

    Provide and compare the number and proportion of patients with both composite and individual outcome of death, circulatory deterioration, respiratory deterioration, administration of reperfusion therapy

    Five days from diagnosis

Secondary Outcomes (2)

  • Compare the prognostic accuracy of different right ventricular dysfunction parameters for predefined clinical deterioration outcomes within 5 days

    5 days from diagnosis

  • Comparison of Patient Reported Pulmonary Embolism Functional outcomes at 30 days after Pulmonary Embolism Diagnosis

    30 days after PE diagnosis

Other Outcomes (1)

  • Development of prediction model for clinical deterioration outcomes within 5 days of PE presentation to emergency department

    5 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who present to the emergency department with image confirmed acute pulmonary diagnosed within 12 hours of presentation

You may qualify if:

  • Men and women, 18 years or older, with image confirmed acute pulmonary embolism diagnosed within 12 hours of ED presentation

You may not qualify if:

  • Patients who decline any participation in the study
  • Patients 17 years old and younger at the time of screening
  • Radiologist's over read that determines that filling defects identified as acute emboli are instead either chronic, resolving, or unchanged after comparison to previous CT, if available
  • If empiric anticoagulation or escalated intervention were initiated more than 12 hours before presentation to the recruiting ED
  • Identification of either segmental or subsegmental intraluminal filling defects on CT that are considered to be clinically incidental and unrelated to primary diagnostic workup or ED presentation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

San Diego Medical Center

San Diego, California, 92120, United States

Location

Christiana Care Health System

Newark, Delaware, 19718, United States

Location

Orlando Regional Medical Center

Orlando, Florida, 32806, United States

Location

Carolinas Medical Center - Main

Charlotte, North Carolina, 28203, United States

Location

Vanderbilt Medical Center

Nashville, Tennessee, 37232, United States

Location

Univeristy of Utah Hospital

Salt Lake City, Utah, 84132, United States

Location

MeSH Terms

Conditions

Pulmonary Embolism

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Anthony Weekes, MD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2019

First Posted

April 16, 2019

Study Start

September 30, 2018

Primary Completion

November 30, 2020

Study Completion

November 30, 2020

Last Updated

April 27, 2022

Record last verified: 2019-07

Locations